Krystal Biotech, Inc. (KRYS) Tops Q3 EPS by 2c

Krystal Biotech, Inc. (NASDAQ: KRYS) reported Q3 EPS of ($1.17), $0.02 better than the analyst estimate of ($1.19).

For earnings history and earnings-related data on Krystal Biotech, Inc. (KRYS) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Credo Technology pops 3.5% as Evercore initiates with monster $325 price target
• Morgan Stanley sees little room left in steel rally, cuts Cleveland-Cliffs rating